Turning Point Benefit Group’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$466K Sell
19,600
-25,983
-57% -$620K 0.2% 72
2026
Q1
$1.09M Buy
45,583
+15,285
+50% +$368K 0.69% 36
2025
Q4
$733K Sell
30,298
-8,514
-22% -$206K 0.38% 46
2025
Q3
$938K Sell
38,812
-3,586
-8% -$86.3K 0.57% 37
2025
Q2
$1.02M Buy
+42,398
New +$1.01M 0.77% 26
2025
Q1
Sell
-44,973
Closed -$1.05M 69
2024
Q4
$1.05M Buy
+44,973
New +$1.07M 1% 14

Other funds holding IBD

Turning Point Benefit Group's IBD Position: Q2 2026 in Review

Turning Point Benefit Group reduced its Inspire Corporate Bond ETF (IBD) stake by 57% in Q2 2026, selling an estimated $620K and leaving 19,600 shares worth $466K. The position accounts for 0.2% of the portfolio, ranked #72.

Turning Point Benefit Group first reported a position in IBD in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.09M in Q1 2026. 110 funds tracked by Wall St. Rank hold IBD as of Q2 2026.

  • Turning Point Benefit Group held 19,600 shares of Inspire Corporate Bond ETF worth $466K as of Q2 2026.
  • Turning Point Benefit Group sold 25,983 Inspire Corporate Bond ETF shares in Q2 2026, an estimated $620K.
  • Inspire Corporate Bond ETF made up 0.2% of Turning Point Benefit Group's portfolio in Q2 2026, its #72 holding.
  • Turning Point Benefit Group first reported a position in Inspire Corporate Bond ETF in Q4 2024 and has held it in 6 quarters since.
  • Turning Point Benefit Group's Inspire Corporate Bond ETF position peaked at $1.09M in Q1 2026.
  • 110 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q2 2026.

Based on Turning Point Benefit Group's 13F filing for Q2 2026, filed 23 Jul 2026.